BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 17143813)

  • 1. Routine use of the Pneumonia Severity Index for guiding the site-of-treatment decision of patients with pneumonia in the emergency department: a multicenter, prospective, observational, controlled cohort study.
    Renaud B; Coma E; Labarere J; Hayon J; Roy PM; Boureaux H; Moritz F; Cibien JF; Guérin T; Carré E; Lafontaine A; Bertrand MP; Santin A; Brun-Buisson C; Fine MJ; Roupie E;
    Clin Infect Dis; 2007 Jan; 44(1):41-9. PubMed ID: 17143813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reasons why emergency department providers do not rely on the pneumonia severity index to determine the initial site of treatment for patients with pneumonia.
    Aujesky D; McCausland JB; Whittle J; Obrosky DS; Yealy DM; Fine MJ
    Clin Infect Dis; 2009 Nov; 49(10):e100-8. PubMed ID: 19842971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hospital admission decision for patients with community-acquired pneumonia. Results from the pneumonia Patient Outcomes Research Team cohort study.
    Fine MJ; Hough LJ; Medsger AR; Li YH; Ricci EM; Singer DE; Marrie TJ; Coley CM; Walsh MB; Karpf M; Lahive KC; Kapoor WN
    Arch Intern Med; 1997 Jan; 157(1):36-44. PubMed ID: 8996039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical judgment versus the Pneumonia Severity Index in making the admission decision.
    Seymann G; Barger K; Choo S; Sawhney S; Davis D
    J Emerg Med; 2008 Apr; 34(3):261-8. PubMed ID: 18180134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.
    Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA
    Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alveolar-arterial oxygen gradient, pneumonia severity index and outcomes in patients hospitalized with community acquired pneumonia.
    Moammar MQ; Azam HM; Blamoun AI; Rashid AO; Ismail M; Khan MA; DeBari VA
    Clin Exp Pharmacol Physiol; 2008 Sep; 35(9):1032-7. PubMed ID: 18518885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study--a randomized clinical trial.
    Torres A; Garau J; Arvis P; Carlet J; Choudhri S; Kureishi A; Le Berre MA; Lode H; Winter J; Read RC;
    Clin Infect Dis; 2008 May; 46(10):1499-509. PubMed ID: 18419482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of a pneumonia severity index in the optimization of the diagnostic and therapeutic effort for community-acquired pneumonia.
    Ortega L; Sierra M; Domínguez J; Martínez J; Matas L; Bastart F; Galí N; Ausina V
    Scand J Infect Dis; 2005; 37(9):657-63. PubMed ID: 16126566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical policy for management and risk stratification of community-acquired pneumonia in patients hospitalized on the basis of conventional admission criteria].
    Putinati S; Ballerin L; Piattella M; Ritrovato L; Zabini F; Potena A
    Recenti Prog Med; 2003 May; 94(5):199-203. PubMed ID: 12723497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial antibiotic selection and patient outcomes: observations from the National Pneumonia Project.
    Bratzler DW; Ma A; Nsa W
    Clin Infect Dis; 2008 Dec; 47 Suppl 3():S193-201. PubMed ID: 18986289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome predictors of pneumonia in elderly patients: importance of functional assessment.
    Torres OH; Muñoz J; Ruiz D; Ris J; Gich I; Coma E; Gurguí M; Vázquez G
    J Am Geriatr Soc; 2004 Oct; 52(10):1603-9. PubMed ID: 15450034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using randomized controlled trial data, the agreement between retrospectively and prospectively collected data comprising the pneumonia severity index was substantial.
    Aujesky D; Stone RA; Obrosky DS; Yealy DM; Auble TE; Meehan TP; Graff LG; Fine JM; Fine MJ
    J Clin Epidemiol; 2005 Apr; 58(4):357-63. PubMed ID: 15862721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Admission D-dimer can identify low-risk patients with community-acquired pneumonia.
    Chalmers JD; Singanayagam A; Scally C; Hill AT
    Ann Emerg Med; 2009 May; 53(5):633-8. PubMed ID: 19201061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levofloxacin versus ceftriaxone plus clarithromycin in the treatment of adults with community-acquired pneumonia requiring hospitalization.
    Querol-Ribelles JM; Tenías JM; Querol-Borrás JM; Labrador T; Nieto A; González-Granda D; Martínez I
    Int J Antimicrob Agents; 2005 Jan; 25(1):75-83. PubMed ID: 15620830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between timing of intensive care unit admission and outcomes for emergency department patients with community-acquired pneumonia.
    Renaud B; Santin A; Coma E; Camus N; Van Pelt D; Hayon J; Gurgui M; Roupie E; Hervé J; Fine MJ; Brun-Buisson C; Labarère J
    Crit Care Med; 2009 Nov; 37(11):2867-74. PubMed ID: 19770748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of delayed oxygenation assessment on time to antibiotic delivery and mortality in patients with severe community-acquired pneumonia.
    Blot SI; Rodriguez A; Solé-Violán J; Blanquer J; Almirall J; Rello J;
    Crit Care Med; 2007 Nov; 35(11):2509-14. PubMed ID: 17901833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A validation and potential modification of the pneumonia severity index in elderly patients with community-acquired pneumonia.
    Naito T; Suda T; Yasuda K; Yamada T; Todate A; Tsuchiya T; Sato J; Chida K; Nakamura H
    J Am Geriatr Soc; 2006 Aug; 54(8):1212-9. PubMed ID: 16913987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levofloxacin 750-mg for 5 days for the treatment of hospitalized Fine Risk Class III/IV community-acquired pneumonia patients.
    Shorr AF; Khashab MM; Xiang JX; Tennenberg AM; Kahn JB
    Respir Med; 2006 Dec; 100(12):2129-36. PubMed ID: 16730170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etiology, reasons for hospitalization, risk classes, and outcomes of community-acquired pneumonia in patients hospitalized on the basis of conventional admission criteria.
    Rosón B; Carratalà J; Dorca J; Casanova A; Manresa F; Gudiol F
    Clin Infect Dis; 2001 Jul; 33(2):158-65. PubMed ID: 11418874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A teaching hospital's experience applying the Pneumonia Severity Index and antibiotic guidelines in the management of community-acquired pneumonia.
    Lee RW; Lindstrom ST
    Respirology; 2007 Sep; 12(5):754-8. PubMed ID: 17875067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.